Prenatal and Newborn Genetic Testing Market is Slated to Witness Tremendous Revenue Growth of US$ 11,204.7 Mn in 2027 in Coming Years: 2021-2027

According to The Insight Partners market research study titled Prenatal and Newborn Genetic Testing Market - Global Analysis and Forecasts by Product, Disease Indication and End User. The Global Prenatal and Newborn Genetic Testing Market is expected to reach US$ 11,204.7 Mn in 2027 from US$ 4,034.4 in 2018. The market is estimated to grow with a CAGR of 12.2% from 2019-2027. The report highlights the trends prevalent in the global prenatal and newborn genetic testing market and the factors driving the market along with those that act as deterrents to its growth.

Prenatal genetic testing is performed during the pregnancy for the diagnosis of the diseases or detection of specific genetic abnormalities before 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Most of the prenatal genetic tests use a blood sample from the mother for conduction of various screens. Diagnostic methods are more effective, accurate, and a preferred option for the detection of chromosome abnormalities as compared to the screening methods. The growth of the global prenatal and newborn genetic testing market is attributed to the increase in the prevalence of genetic diseases among infants, supportive government for promoting the use of prenatal and newborn testing and increasing birth rate. However, risk associated with prenatal genetic tests is the major factor hindering the market growth.

To get sample Copy of the report, along with the TOC, Statistics @
https://www.theinsightpartners.com/sample/TIPBT00002550/?utm_source=OpenPR&utm_medium=10411

Here we have listed the top Prenatal and Newborn Genetic Testing Market companies

Abbott, Quest Diagnostics Incorporated, Ravgen, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann La-Roche Ltd., Qiagen, Berry Gene, PerkinElmer, Inc., Natera, Inc., and Laboratory Corporation of America Holdings (Sequenom) among others.

Global Prenatal and Newborn Genetic Testing Market - By Product

• Diagnostic
o Spectrophotometer
o Polymerase Chain Reaction
o Fluorescence in-situ Hybridization
o Array-Comparative Genomic Hybridization
• Screening
o Maternal Serum Screening
o Chronic Villus Sampling
o Amniocentesis
o Non-invasive Prenatal Testing

Global Prenatal and Newborn Genetic Testing Market - By Disease Indication

• Cystic Fibrosis
• Sickle Cell Anemia
• Down Syndrome
• Other Diseases

Global Prenatal and Newborn Genetic Testing Market - By End User

• Hospitals & Clinics
• Diagnostic Centers
• Other End Users

Highlights the following key factors:

1) Business description-A detailed description of the company's operations and business divisions.
2) Corporate strategy - Analyst's summarization of the company's business strategy.
3) SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities, and threats.
4) Company history - Progression of key events associated with the company.
5) Major products and services-A list of major products, services, and brands of the company.
6) Key competitors - A list of key competitors to the company.
7) Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
8) Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 7 years history.

Have Question? Speak to Analyst at:
https://www.theinsightpartners.com/speak-to-analyst/TIPBT00002550/?utm_source=OpenPR&utm_medium=10411

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Prenatal and Newborn Genetic Testing Market based on product and application. It also provides market size and forecast till 2028 for overall Prenatal and Newborn Genetic Testing Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prenatal and Newborn Genetic Testing Market - By Product Type
1.3.2 Prenatal and Newborn Genetic Testing Market - By Pressure Type
1.3.3 Prenatal and Newborn Genetic Testing Market - By Application
1.3.4 Prenatal and Newborn Genetic Testing Market - By End User
1.3.5 Prenatal and Newborn Genetic Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PRENATAL AND NEWBORN GENETIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PRENATAL AND NEWBORN GENETIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

Place a Purchase Order to Buy a Complete Copy of this Report @
https://www.theinsightpartners.com/buy/TIPBT00002550/?utm_source=OpenPR&utm_medium=10411

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.